<code id='C4BD12E12B'></code><style id='C4BD12E12B'></style>
    • <acronym id='C4BD12E12B'></acronym>
      <center id='C4BD12E12B'><center id='C4BD12E12B'><tfoot id='C4BD12E12B'></tfoot></center><abbr id='C4BD12E12B'><dir id='C4BD12E12B'><tfoot id='C4BD12E12B'></tfoot><noframes id='C4BD12E12B'>

    • <optgroup id='C4BD12E12B'><strike id='C4BD12E12B'><sup id='C4BD12E12B'></sup></strike><code id='C4BD12E12B'></code></optgroup>
        1. <b id='C4BD12E12B'><label id='C4BD12E12B'><select id='C4BD12E12B'><dt id='C4BD12E12B'><span id='C4BD12E12B'></span></dt></select></label></b><u id='C4BD12E12B'></u>
          <i id='C4BD12E12B'><strike id='C4BD12E12B'><tt id='C4BD12E12B'><pre id='C4BD12E12B'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:44
          The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT
          Eric Risberg/AP

          Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

          These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

          advertisement

          Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Eli Lilly reports tirzepatide MASH success during Q4 earnings
          Eli Lilly reports tirzepatide MASH success during Q4 earnings

          DarronCummings/APTheblockbusterweightlossanddiabetesdrugsoldbyEliLillyalsoappearstoimprovefattyliver

          read more
          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more

          Humana cuts profit projections as Medicare Advantage costs soar

          AdobeHumana’sMedicareAdvantageenrolleesgotcareinthehospitalandphysicianclinicswaymoreoftenthanthecom